Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.

Abstract

Glutamatergic dysfunction has been implicated in psychiatric disorders such as schizophrenia. Both the stimulation of the metabotropic glutamate (mGlu) 2/3 receptor and the blockade of the mGlu1 receptor have been shown to be effective in a number of animal models of schizophrenia. However, the efficacy for social cognition, which is poorly managed by current medication, has not been fully addressed. The present study evaluated the effects of an mGlu2/3-receptor agonist and an mGlu1-receptor antagonist on social memory impairment in rats. Pretreatment with an mGlu2/3-receptor agonist, (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), or an mGlu1-receptor antagonist, (3,4-dihydro-2H-pyrano[2,3-b]quinolin-7-yl)-(cis-4-methoxycyclohexyl)-methanone (JNJ16259685), improved social memory impairment induced by 5R,10S-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK-801) without affecting the social interactions. In addition, the intraperitoneal administration of an mGlu2-receptor potentiator, 3'-[[(2-cyclopentyl-2,3-dihydro-6,7-dimethyl-1-oxo-1H-inden-5-yl)oxy]methyl]-[1,1'-biphenyl]-4-carboxylic acid (BINA), also improved the MK-801-induced impairment of social memory, which was blocked by pretreatment with an mGlu2/3-receptor antagonist, (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495). These findings indicate that both the stimulation of the mGlu2 receptor and the inhibition of an mGlu1 receptor improve social memory impairment elicited by MK-801, and both manipulations could be effective approaches for the treatment of certain cognitive dysfunctions observed in schizophrenic patients.

• Authors: Hirohiko Hikichi, Ayaka Kaku, Jun-ichi Karasawa, Shigeyuki Chaki
• Journal: Journal of pharmacological sciences (J Pharmacol Sci) Vol. 122 Issue 1 Pg. 10-6 ( 2013) ISSN: 1347-8648 [Electronic] Japan
• PMID: 23603933 (Publication Type: Journal Article)

Chemical References

• (3,4-dihydro-2H-pyrano(2,3)b-quinolin-7-yl)-(cis-4-methoxycyclohexyl) methanone
• Amino Acids
• Bridged Bicyclo Compounds, Heterocyclic
• Excitatory Amino Acid Antagonists
• LY 341495
• LY 379268
• Quinolines
• Receptors, Metabotropic Glutamate
• Xanthenes
• metabotropic glutamate receptor 2
• metabotropic glutamate receptor 3
• metabotropic glutamate receptor type 1
• Dizocilpine Maleate

Topics

• Amino Acids (pharmacology, therapeutic use)
• Animals
• Bridged Bicyclo Compounds, Heterocyclic (pharmacology, therapeutic use)
• Dizocilpine Maleate (adverse effects)
• Excitatory Amino Acid Antagonists (pharmacology, therapeutic use)
• Male
• Memory Disorders (chemically induced, drug therapy, physiopathology)
• Quinolines (pharmacology, therapeutic use)
• Rats
• Rats, Sprague-Dawley
• Receptors, Metabotropic Glutamate (agonists, antagonists & inhibitors, physiology)
• Recognition, Psychology (drug effects)
• Xanthenes (pharmacology, therapeutic use)